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Tuberculosis contact investigations are a top priority in TB infection control. The aim is to prevent the
spread of infectious disease, identify potential TB sources, and treat individuals who are infected or
actively ill. The contact investigation process is quite simple: identify close contacts; examine their
symptoms and determine their clinical status; perform a chest X-ray; administer a tuberculin skin test
and/or interferon gamma release assay; and evaluate the results. This communication documents a TB
contact investigation that was conducted in one family during the months after the initial TB ﬁnding.
Investigations of close family contacts found active TB in 3 individuals and latent TB in 1 unvaccinated
child. This conﬁrms that contact investigations are an easy intervention that results in rapid identiﬁ-
cation of TB sources. Treatment of these patients reduces the risk of exposure and spread of infection to
additional community members [1].
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
At present, tuberculosis (TB) is the most widespread infectious
disease in the world. The Czech Republic has one of the lowest
annual TB incidence rates in Central Europe. In 2014, a total of 512
cases of TB disease were reported, which represents 5.0 cases per
100,000 inhabitants. 75% of new pulmonary TB disease cases were
found while examining patients for health complaints (passive
search method). TB contact investigations were conducted in 8% of
these cases (active search method). The Mycobacterium tubercu-
losis complex is the causative agent of TB, the source of which is
primarily ill individuals, but also carriers. TB symptoms are not
usually overly pronounced; patients suffer fatigue, perspiration,
elevated temperatures, coughing, and weight loss.
In 1953, the former Czechoslovakia launched a blanket vacci-
nation campaign against TB. In the 1950s, all infants and older
children were vaccinated to facilitate rapid vaccination coverage of
the population. From the early 1960s until 2009, vaccinations were
administered to infants; older children (at 11 years of age) with
negative tuberculin skin test (TST) results, also received vaccina-
tions. In 2010, the Czech Republic discontinued the blanket vacci-
nation campaign for infants; selective TB vaccination is currently
designated for children at risk of contracting TB [2]. This commu-
nication presents the TB contact investigation of one family.r Ltd. This is an open access article u1.1. Case report no. 1
The patient was a 48-year-old male, smoker (30 pack-years), but
not yet seriously ill. The patient was vaccinated against TB as a
child. He is married and resides in an apartment with his family.
The patient arrived at the hospital complaining of sudden he-
moptysis. He reported that he had been coughing more than usual
during the last month and had been short of breath upon exertion.
He was afebrile and had lost 20 kg over the course of 9 months. A
posteroanterior chest X-ray showed diffuse bilateral inﬁltrates
(Fig. 1). A sputum examination repeatedly demonstrated massive
smear positivity and a ﬁnding of acid-fast bacilli, which was fol-
lowed by culture positivity 3 weeks later. A Bactec MGIT 960 ex-
amination produced a positive result on the 8th day and PCR tests
results were also positive. The Mantoux TST showed an induration
of þ15 mm. Typing demonstrated Mycobacterium tuberculosis
complex (MTB) with preserved sensitivity to ﬁrst-line antituber-
culous medications. HIV test results were negative. First-line anti-
tuberculosis treatment (AT) was started immediately with a
combination of rifampicin, isoniazid, ethambutol and pyr-
azinamide. After 2 months, sputum samples were both culture-
negative and smear-negative for MTB. Given the extent of the dis-
ease, the initial phase of AT treatment was extended to 3 months,
with a follow-on phase of bi-therapy with rifampicin and isoniazid
for 6 months. Treatment was effective with no adverse effects.
Radiograph ﬁndings gradually regressed and the patient’s clinical
condition improved signiﬁcantly (Fig. 2).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Posteroanterior chest X-ray showed.
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contact investigation.1.2. Case report no. 2
The patient was a 47-year-old female, smoker (31 pack-years),
employed as a maid, presenting as not seriously ill. The patient
resides in the same household as her husband and was vaccinated
against TB as a child. She visited the hospital for the purpose of
undergoing a TB contact investigation. No reported pulmonary
complaints, apart from a long-standing cough in the mornings. She
was afebrile, no reported weight loss, no perspiration. The TST was
positive with an induration of þ16 mm; HIV test results were
negative. A chest X-ray showed inﬁltrates in the upper right and
middle ﬁelds on both right and left sides. Sputum tests were
repeatedly smear-negative, but culture and Bactec MGIT 960 tests
were positive. Genome testing demonstrated a positive ﬁnding of
theMTB gene. Sensitivity to ﬁrst-line AT was preserved; the patient
started AT treatment with the same combination used for her
husband (an initial phase lasting 2 months, and a follow-on phase
lasting 4 months).Fig. 2. Regression of bilateral diffuse inﬁtrates diffuse bilateral inﬁltrates after 3
months AT treatment.1.3. Case report no. 3
The third report involves the daughter of the aforementioned
married couple: a 23-year-old female, vaccinated against TB as a
child, mother of a 4-year-old child, smoker since youth (6 pack-
years), presenting as not yet seriously ill. The patient occasionally
works as a waitress in a bar and resides with her son and parents in
the same apartment. She participated in the TB contact investiga-
tion on the basis of being a close contact of her father. During the
previous month, the patient noticed a cough and weight loss of
3 kg. She was afebrile, no perspiration, and reportedly felt quite
well. TST results showed an induration of þ16 mm; HIV test results
were negative. A chest X-ray showed ﬁndings of pulmonary in-
ﬁltrates in both lungs with numerous caverns in the right upper
lobe (Fig. 3).
The patient was hospitalized immediately. Sputum was smear-
positive and culture-positive for MTB for a period of 2 months.
Mycobacterium testing with the BactecMGIT 960 was also positive.
The patient was started on ﬁrst-line AT therapy with a combination
of rifampicin, isoniazid, ethambutol, and pyrazinamide. Her
sputum was smear-positive and culture-positive for MTB for a
period of 2 months. Given the extent of the ﬁndings, the initial
phase was extended to three months, and the follow-on phase
involved bi-therapy with rifampicin and isoniazid in a daily regime
for 4 months.
1.4. Case report no. 4
The patient was the 4-year-oldmale, son of the abovementioned
23-year-old patient. The child had never been vaccinated against TB
due to the lack of TB risk within the family. He resides in the same
household as his mother and grandparents. The family reported no
health problems for the child. A posterior-anterior chest X-ray
showed no pathology in the lung parenchyma. TST results showed
an induration of þ16 mm and Interferon gamma release assay
(IGRA test) was positive. As a very close family contact, the boy was
started on isoniazid chemoprophylaxis at a dose of 5 mg/kg of body
weight, which was continued for 6 months as treatment for an
identiﬁed latent tuberculosis infection.Fig. 3. Pulmonary inﬁltrates in both lungs with numerous caverns in the right upper
lobe.
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Individuals who have had close and frequent contact with per-
sons with bacteriologically proven TB undergo TB contact in-
vestigations [3]. These individuals are referred for radiographic and
bacteriological examinations and TST and/or IGRA tests are also
administered. A TB contact investigation of four individuals in one
family found TB disease in three adults and a latent TB infection in a
4-year-old boy (the only family member who had never been
vaccinated). None of the adults were aware of having had contact
with other individuals who had been diagnosed with TB. In addi-
tion, none of these 3 patients had been seriously ill recently. Apart
from chronic nicotinism, no other risk factors or severe concomi-
tant diseases were present in any family member. Symptoms were
not overt in any of these individuals. Patient 1 was alarmed when
he experienced sudden hemoptysis, for which he sought medical
attention. Patients 2 and 3 were examined during the month
following TB detection in Patient 1. Were it not for initiatives aimed
at investigating close contacts, these 2 female TB patients would
not have soughtmedical attention of their own volitione and it can
be assumed their TB infections would have spread to other in-
dividuals. The range of cavernous X-ray ﬁndings was widest in
Patient 1, and he had the most severe disease symptoms. This
suggests that Patient 1 was the primary TB infection source for the
other members of the household. Apart from chronic tobacco use,
no other risks that might have triggered TB disease were found in
Patient 1. The 2 most serious sources of TB infection in the family
were Patients 1 and 3, for whom sputum was repeatedly smear-
positive and culture-positive for acid-fast bacilli.
It is clear that the most signiﬁcant sources of TB infection are
patients with smear-positive sputum samples, or those with lung
tissue decay. Due to the advanced nature of their disease, these
types of patients are believed to be infectious for up to 3 months.
Patients with ﬁndings of culture-positive sputum pose a risk to
those in their surroundings for approximately one month [1]. Ac-
cording to a number of published studies TB disease prevalence is
3.1% in investigated contacts, while latent TB infection prevalence is
51.5%. Similarly, TB prevalence in family contacts is 3.1%. The inci-
dence of TB in contacts is highest in the ﬁrst year after exposure to
TB [4]. In the Czech Republic, 8% of contact investigations con-
ducted eachyear result in ﬁndings of TB [2]. Findings during contact
investigations assume an up to 10-times higher detection than the
estimated TB prevalence in the general population.
Contact investigations of individuals with respiratory symp-
toms, as well as familial child contacts, are particularly beneﬁcial
[4]. The median incubation period is 6 weeks [1]. TB contact
investigation results are inﬂuenced by the duration, proximity and
intensity of exposure to ill individuals [6]. The 4-year-old child was
the only family member who did not have TB disease; but he did
have a latent TB infection. At the same time, the boy was the only
family member who had never been vaccinated against TB.
A latent TB infection is deﬁned as a putative infection that is
identiﬁed via a positive TST and/or positive interferon g release
assay (IGRA) with an absence of clinical and x-ray ﬁndings [1].According to the World Health Organization recommendations for
infected individuals, preventive therapy with isoniazid prevents
progression to TB disease [7]. Preventive treatment of latent
tuberculosis infections is a particularly important component of TB
control strategies in countries with low TB incidence, such as the
Czech Republic [6].
3. Conclusion
TB contact investigations for TB patients are a top priority in TB
infection control. Identifying individuals with TB disease and latent
TB infections is an important step in locating TB infection sources
[3]. From an epidemiologically point of view, themost important TB
infection sources are patients with tubercle bacilli in their sputum
in a volume that is detectable via microscopic examination. These
individuals comprise an important target group that represents a
signiﬁcant infectious source of TB known as “open tuberculosis”. To
reduce the spread of tuberculosis infection, it is necessary to search
for undiagnosed and untreated TB patient sources who pose a
considerable risk to those in their environment. Rapid, reliable and
high-quality diagnosis is achieved through clinical, radiologic, and
laboratory ﬁndings. An investigation of close family contacts is
rightly recommended as a strategy for early detection of the dis-
ease.1The aim of TB contact investigations is the reduction of TB
morbidity, interruption of further TB transmission, and preventive
treatment of infected persons to prevent the development of TB
disease [1,7]. Preventive therapy with isoniazid is fully indicated in
patients who, due to the intensity of contact, are at high risk for
developing TB disease (a risk that exceeds the risk of adverse
treatment effects) [5].
This communication demonstrates the importance contact in-
vestigations, which can detect TB disease evenwhen symptoms are
not obvious.
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